Spread of Vancomycin-Resistant Enterococci: Differences between the United States and Europe

Infection Control and Hospital Epidemiology

Volumn 19, Issue 8, 1998, Pages 546-551

  Goossens, Herman ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AVOPARCIN; GLYCOPEPTIDE; VANCOMYCIN;

ANIMAL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CLINICAL PRACTICE; COMPARATIVE STUDY; CROSS INFECTION; DISEASE CARRIER; DOMESTIC ANIMAL; DRUG EFFECT; ENTEROCOCCUS; EUROPE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; PREVALENCE; UNITED STATES;

ANIMALS; ANIMALS, DOMESTIC; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DISEASE VECTORS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ENTEROCOCCUS; EUROPE; GLYCOPEPTIDES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; UNITED STATES; VANCOMYCIN;

EID: 0032130747     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141778     Document Type: Article

References (51)

1. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-161.
2. Jones RN, Sader HS, Erwin ME, Anderson SC, and the Enterococcus Study Group. Emerging multiple resistant enterococci among clinical isolates: I, prevalence data from 97 medical center surveillance study in the United States. Diagn Microbiol Infect Dis 1995;21:85-93.
3. Morris JG Jr, Shay DK, Hebden JN, McCarter RJ Jr, Perdue BE, Jarvis W, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med 1995;123:250-259.
4. Quale J, Landman D, Saurina G, Atwood E, DiTore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996;23:1020-1025.
5. Wells CL, Juni BA, Cameron SB. Stool carriage, clinical isolation and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 1995;21:45-50.
6. Vandamme P, Vercauteren E, Lammens C, Pensart N, Ieven M, Pot B, et al. Survey of enterococcal susceptibility patterns in Belgium. J Clin Microbiol 1996;34:2572-2576.
7. Boisivon A, Thibault M, Leclercq R. Colonization by vancomycin-resistant enterococci of the intestinal tract of patients in intensive care units from French general hospitals. Clinical Microbiology and Infection 1996;3:175-179.
8. Klare I. Heier H, Claus H, Böhme G, Marin S, Seitmann G, et al. Enterococcus faecium strains with vanA mediated high level resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microbial Drug Resistance 1995;1:265-272.
9. Gordts B, Van Landuyt H, Ieven M, Vandamme P, Goossens H. Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microbiol 1995;33:2842-2846.
10. Jordens JZ, Bates J, Griffiths DT. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1994;34:515-528.
11. Endtz HP, van den Braak N, van Belkum A, Kluytmans AJW, Koeleman JGM, Spanjaard M, et al. Fecal carriage of vancomycin resistant enterococci in hospitalized patients and those living in the community in The Netherlands. J Clin Microbiol 1997;35:3026-3031.
12. Coque TM, Tomayko JF, Ricke SC, Okhyusen PC, Murray BE. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother 1996;40:2605-2609.
13. Silverman J, Thai LA, Pern MB, Bostic G, Zervos MJ. Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci. J Clin Microbiol 1998;36:830-832.
14. Devriese LA, Ieven M, Goossens H, Vandamme P, Pot B, Hommez J, et al. Presence of vancomycin-resistant enterococci in farm and pet animals. Antimicrob Agents Chemother 1996;40:2285-2287.
15. Ieven M, Vercauteren E, Descheemaeker P, Goossens H. Significant increase in detection of intestinal carriers of glycopeptide resistant enterococci (GRE) by enrichment cultures. Presented at the 37th International Conference on Antimicrobial Agents and Chemotherapy; 1997; Toronto, Ontario, Canada, 1997:104. Abstract D-118.
16. Van der Auwera P, Pensart N, Korten V, Murray BE, Leclercq R Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis 1996;173:1129-1136.
17. Boyle JF, Soumakis SA, Rendo A, Herrington JA, Gianarkis DG, Thurberg BE, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993;31:1280-1285.
18. Iwen PC, Kelly DM, Under J, Hinrichs SH, Dominguez EA, Rupp ME, et al. Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period. Antimicrob Agents Chemother 1997;41:494-495.
19. Goossens H, Lammens C, Goossens W, Vandamme P, Ieven M, Struelens M. Multicenter in-vitro evaluation of the susceptibility of 1,342 gram-positive cocci isolated from the blood towards cefepime and cefpirome compared to other antibiotics. Presented at the 37th International Conference on Antimicrobial Agents and Chemotherapy; 1997; Toronto, Ontario, Canada, 1997:137. Abstract E-130.
20. Gordon S, Swenson JM, Hill BC, Pigott NE, Facklam RR, Cooksey RC, et al. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J Clin Microbiol 1992;30:2373-2378.
21. Nachamkin I, Axelrod P, Talbot GH, Fischer SH, Wennersten CB, Moellering RC. Multiply high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital. J Clin Microbiol 1988;26:1287-1291.
22. Noskin GA, Till M, Patterson BK, Clarke JT, Warren JR. High-level gentamicin resistance in Enterococcus faecalis bacteremia. J Infect Dis 1991;164:1212-1215.
23. Wurtz R, Sahm D, Flaherty J. Gentamicin-resistant, streptomycin-susceptible Enterococcus (Streptococcus) faecalis bacteremia. J Infect Dis 1991;163:1393-1394.
24. Coque TM, Arduino RC, Murray BE. High-level resistance to aminoglycosides: comparison of nosocomial fecal isolates of enterococci. J Infect Dis 1995;20:1048-1051.
25. Gray JW, Stewart D, Pedler SJ. Faecal carriage of antibiotic-resistant enterococci in hospitalized and non-hospitalized individuals. J Antimicrob Chemother 1992;30:110-112.
26. Schaberg DR, Dillon WI, Terpenning MS, Robinson KA, Bradley SF, Kauffman CA Increasing resistance of enterococci to ciprofloxacin. Antimicrob Agents Chemother 1992;36:2533-2535.
27. Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC. Characterization of glycopeptide-resistant enterococci from US hospitals. Antimicrob Agents Chemother 1993;37:2311-2317.
28. Frieden TR, Munsiff SS, Low DE, Willey BM, Williams G, Faur Y, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993;342:76-79.
29. Rice EW, Messer JW, Johnson CH, Reasoner DJ. Occurrence of high-level aminoglycoside resistance in environmental isolates of enterococci. Appl Environ Microbiol 1995;61:374-376.
30. Thai LA, Chow JW, Mahayni R, Bonilla H, Perri MB, Donabedian SA, et al. Characterization of antimicrobial resistance in enterococci of animal origin. Antimicrob Agents Chemother 1995;39:2112-2115.
31. Descheemaeker P, Chapelle S, Devriese LA, Vandamme P, Goossens H. Transfer of Tn 1546 or related elements, conferring high level glycopeptide resistance among enterococci from animal and human origin. Presented at the Fifth American Society of Microbiology Conference on Streptococcal Genetics; April 26-29, 1998; Vichy, France.
32. Aarestrup FM, Ahrens P, Madsen M. Pallesen LV, Poulsen RL, Westh H. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the vanA cluster. Antimicrob Agents Chemother 1996;40:1938-1940.
33. Handwerger S, Raucher B, Altarac D, Monka J, Marchione S, Singh KV, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750-755.
34. Boyce JM, Opal SM, Chow JW, Zervos MJ, Potter-Bynoe G, Sherman CB, et al. Outbreak of multidrug-resistant Enterococais faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32:1148-1153.
35. Moreno F, Grota P, Grisp C, Magnon K, Melcher GP, Jorgensen JH, et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995;21:1234-1237.
36. Dunne WM Jr, Wang W. Clonal dissemination and colony morphotype variation of vancomycin-resistant Enterococcus faecium isolates in metropolitan Detroit, Michigan. J Clin Microbiol 1997;35:388-392.
37. Bonten MJM, Hayden MK, Nathan C, van Voorhis J, Matushek M, Slaughter S, et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 1996;348:1615-1619.
38. Gordts B, Van Landuyt H, Lambert A, Ieven M, Goossens H. Specific in vitro resistance patterns of glycopeptide resistant enterococci (GRE) collected in a national surveillance study. Presented at the 37th International Conference on Antimicrobial Agents and Chemotherapy: 1997; Toronto, Ontario, Canada, 1997:137. Abstract E-129.
39. Bingen EH, Denamur E, Lambert-Zechovsky NJ, Elion J. Evidence for genetic unrelatedness of nosocomial outbreak of vancomycin-resistant Enterococcus faecium strains in a pediatric hospital. J Clin Microbiol 1991;29:1888-1892.
40. Rao GG, Ojo F, Kolokithas D. Vancomycin-resistant gram-positive cocci: risk factors for faecal carriage. J Hosp Infect 1997;35:63-69.
41. Pegues DA, Pegues CF, Hibberd PL, Ford DS, Hooper DC. Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital. J Clin Microbiol 1997;35:1565-1570.
42. Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, Wenzel RP. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126-1133.
43. Livornese LL Jr, Dias S, Samel C, Romanowski B, Taylor S, May P, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112-116.
44. Kirst HA, Thompson DG, Nicas TI. Historical yearly usage of vancomycin. Antimicrob Agents Chemother 1998;42:1303-1304.
45. Biavasco F, Miele A, Vignaroli C, Manso E, Lupidi R, Varaldo PE. Genotypic characterization of a nosocomial outbreak of vanA Enterococcus faecalis. Microbial Drug Resistance 1996;2:231-237.
46. Boyce JM, Opal SM, Potter-Bynoe G, LaForge RG, Zervos MJ, Furtado G, et al. Emergence and nosocomial transmission of ampicillin-resistant enterococci. Antimicrob Agents Chemother 1992;36:1032-1039.
47. Boyce JM, Mermel LA, Zervos MJ, Rice LB, Potter-Bynoe G, Giorgio C, et al. Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1995;16:634-637.
48. Mato R, De Lencastre H, Roberts RB, Tomasz A. Multiplicity of genetic backgrounds among vancomycin-resistant Enterococcus faecium isolates recovered from an outbreak in a New York City hospital. Microb Drug Res 1996;2:309-317.
49. Grayson ML, Eliopoulos GM, Wennersten CB, Ruoff KL, De Girolami PC, Ferraro MJ, et al. Increasing resistance to β-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother 1991;35:2180-2184.
50. Fridkin SK, Ykoe DS, Whitney CG, Onderdonk A, Hooper D. Epidemiology of a dominant clonal strain of vancomycin-resistant Enterococcus faecium at separate hospitals in Boston, Massachusetts. J Clin Microbiol 1998;36:965-970.
51. Descheemaeker P, Ieven M, Chapelle S, Lammens C, Hauchecorne M, Wijdooghe M, et al. Epidemiology of vancomycin resistant enterococci in Belgian renal dialysis patients. Presented at the Fifth American Society of Microbiology Conference on Streptococcal Genetics; April 26-29,1998; Vichy, France.